1Esmon CT, Owen WG. Identification of an endothelial cell cofactor for the Thrombin-Catalyzed activation of Protein C[J] .Proc Nail Acad Sci USA, 1981.78(4) :2249-2252.
2Nawa K,Sakano K,Fujiwara H,et al . Presence and function of chondroitin-4-sulfate on recombinant human soluble thrombomodulin [J].Biochem Biophy Res Commun, 1990,171(2) :729-737.
3Kokame K, Zheng X, Sadie J. Actiratin of thrombin-activatable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C[J] .J Biol Chem,1998.273(20) : 12135-12139.
4Suzuki K,Hayashi T,Nishioka J, et al.A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and protein C activation[J] .J Biol Chem, 1989,264(9) :4872-4876.
5Petersen TE. The amino-terminal domain of thrombomodulin and pancreatic stone protein are homologous with lectins[J]. FEBS Lett, 1988,231(1) :51-55.
6Drickamer K. Two distinct classes of carbohydrate-recognition domains in animal leetins[J] .J Biol Chem, 1988,263(20):9557-9560.
7Le Flem L,Picard V, Emmerich J, et al. Mutations in promoter region of thrombomodulin and venous thromboembolic disease [J]. Arterioscler Thromb Vasc Biol, 1999,19(4) : 1098-1104.
8Conway EM, Van de Wouwer M, Pollefeyt S, et al. The lectin-like domain of thromhomodulin confers by suppressing adhesin activated protein kinase pathways[J] .J Exp Med,2002,196(5) :565-577.
9Li YH, Chen JH, Wu HL,et al. G-33A mutation in the promoter region of thrombomodulin gene and its association with coronary artery disease and phsma soluble thrombomodulin leveh[J]. Am J Cardiol, 2000,85(1) :8-12.
1[1]Blann AD, Taberner DA. Are liable marker of endothelial cell dysfunction: does it exist? [J] Br J Haematol, 1995, 2: 224-229.
2[2]Salomaa V, Wu KK. Soluble thrombomodulin as predictor of incident coronary heart disease[J]. Lancet,1999, 354: 1646-1647.
3[3]Boehme MW, Raeth U, Scherbaum WA, et al. Interaction of endothelial cells and neutrophils in vitro: kinetics of thrombomodulin, intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vascular cell adhesion molecule-1 (VCAM-1): implications for the relevance as serological disease activity markers in vasculitides[J]. Clin Exp Immunol, 2000, 119: 250-254.
4[4]Blann AD, McCollum CN. yon Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis[J]. Blood Coagul Fibrinolysis, 1999,10: 375-380.
1Blann AD, Tabemer DA, Are liable marker of endothelial cell dysfunction:does it exist[J]. Br J Haematol,1995,90(2) :224-229.
2Salemaa V, Wu KK. Soluble thrombomodulin as predictor of incident coronary heart disease[J]. Lancet,1999,353(9166) :1729-1734.
3Conway EM, Vande W. The lectin-like domain of thrombomodulin confers by suppressing adhesin activated protein kinase pathways [ J]. The Journal of Experimental Medicine, 2002, 196 ( 5 ) : 565- 577.
4Li YH,Chen JH,Wu HL,et al. G-33A mutation in the promoter rogion of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels[ J]. Am J Cardiol,2000,85(1 ) :8-12.
5Blann AD, Tabemer DA. Are liable marker of endothelial cell dysfunction:does it exlst[J]. Br J Haematol,1995,90(2) :224-228.
